PMC:7784830 / 26835-27103
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 429 | 51-54 | Gene | denotes | WT1 | Gene:7490 |
| 431 | 253-261 | Species | denotes | patients | Tax:9606 |
| 434 | 25-31 | Disease | denotes | Cancer | MESH:D009369 |
| 435 | 167-170 | Disease | denotes | HPC | MESH:C537262 |
| 436 | 246-252 | Disease | denotes | cancer | MESH:D009369 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T9 | 25-31 | Phenotype | denotes | Cancer | http://purl.obolibrary.org/obo/HP_0002664 |
| T10 | 246-252 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T210 | 0-268 | Sentence | denotes | Nitto Denko Corporation Cancer vaccine comprising WT1 peptide or Db126 along with a promoter namely lipopolysaccharide or quercetin or ioxoprofen Mannitol, PEG, and HPC PEG, mannitol SCM Composition successfully induces cellular immunity in cancer patients [127] |